tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

Oryzon Genomics Announces Bond-to-Share Conversion
Company AnnouncementsOryzon Genomics Announces Bond-to-Share Conversion
12d ago
ORYZON reports financial results and corporate update for half-year ending June 30, 2024
PremiumPress Releases
ORYZON reports financial results and corporate update for half-year ending June 30, 2024
25d ago
ORN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ORN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Oryzon Genomics Bonds Converted to Shares
PremiumCompany Announcements
Oryzon Genomics Bonds Converted to Shares
1M ago
ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
PremiumPress Releases
ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
2M ago
Oryzon Genomics Expands Capital with New Shares
PremiumCompany AnnouncementsOryzon Genomics Expands Capital with New Shares
2M ago
Oryzon Genomics Shareholders Approve Capital Boost
Premium
Company Announcements
Oryzon Genomics Shareholders Approve Capital Boost
2M ago
ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
Premium
Press Releases
ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
2M ago
Oryzon Genomics Finalizes Capital Increase
PremiumCompany Announcements
Oryzon Genomics Finalizes Capital Increase
2M ago
Oryzon Genomics Announces Capital Increase and New Shares
PremiumCompany Announcements
Oryzon Genomics Announces Capital Increase and New Shares
2M ago
ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
PremiumPress Releases
ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
2M ago
Oryzon Genomics Boosts Capital with New Shares
PremiumCompany Announcements
Oryzon Genomics Boosts Capital with New Shares
2M ago
Oryzon Genomics Announces Capital Increase
PremiumCompany AnnouncementsOryzon Genomics Announces Capital Increase
2M ago
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
Premium
Press Releases
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
2M ago
ORYZON to Provide Corporate Progress Updates at Several Events in May
Premium
Press Releases
ORYZON to Provide Corporate Progress Updates at Several Events in May
4M ago
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
PremiumPress Releases
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
4M ago
Oryzon Genomics (ORN) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Oryzon Genomics (ORN) Q1 Earnings Cheat Sheet
4M ago
ORYZON Secures Another Important Patent for its Lead CNS Asset, Vafidemstat
PremiumPress Releases
ORYZON Secures Another Important Patent for its Lead CNS Asset, Vafidemstat
4M ago
ORYZON to Provide Corporate Progress Updates at Several Events in April
PremiumPress Releases
ORYZON to Provide Corporate Progress Updates at Several Events in April
5M ago
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
PremiumPress ReleasesORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
6M ago
ORYZON to Provide Corporate Progress Updates at Several Events in February-March
Premium
Press Releases
ORYZON to Provide Corporate Progress Updates at Several Events in February-March
7M ago
ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Borderline Personality Disorder on January 25, 2024
Premium
Press Releases
ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Borderline Personality Disorder on January 25, 2024
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >